Scholarlink

Purpose <p>Hirschsprung-associated enterocolitis (HAEC) remains a major cause of morbidity, with poorly defined triggers and limited modifiable risk factors. Given the roles of immune immaturity and mucosal dysfunction in HAEC pathogenesis, this study evaluated whether age is associated with HAEC risk, and whether seasonal variation consistent with viral exposure is present.</p> Methods <p>A retrospective cohort study was conducted including patients with HD treated at Children’s Hospital Colorado (2008–2021). A piecewise exponential Poisson regression model estimated age-specific HAEC incidence rates, adjusting for Trisomy 21 and length of aganglionosis. Seasonal distribution was assessed using an exact binomial test comparing cold (October–March) versus warm months.</p> Results <p>Among 217 patients, 96 HAEC episodes were identified in 53 patients (24.4%). HAEC incidence was highest in the first year of life and declined progressively with age, with an 88% reduction in patients older than 36 months (RR 0.12, 95% CI 0.07–0.22, <i>p</i> &lt; 0.001). Additionally, 60.4% of episodes occurred during cold months, exceeding expected distribution (<i>p</i> = 0.03).</p> Conclusion <p>HAEC risk is strongly age-dependent, with a marked reduction after 36 months, supporting a role for immune maturation in disease susceptibility. The observed seasonal pattern suggests that viral exposures may act as triggers in susceptible patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Age and seasonality in Hirschsprung-associated enterocolitis risk: a longitudinal cohort study

  • 期刊论文

  • 发表日期：

    2026年7月1日

查看全文
  • Sergio Alzate-Ricaurte,
  • Isabella Bielicki,
  • Jill Ketzer,
  • Jill Kaar,
  • Hannah Martin,
  • Alberto Peña,
  • Luis De la Torre,
  • Andrea Bischoff

摘要

Purpose

Hirschsprung-associated enterocolitis (HAEC) remains a major cause of morbidity, with poorly defined triggers and limited modifiable risk factors. Given the roles of immune immaturity and mucosal dysfunction in HAEC pathogenesis, this study evaluated whether age is associated with HAEC risk, and whether seasonal variation consistent with viral exposure is present.

Methods

A retrospective cohort study was conducted including patients with HD treated at Children’s Hospital Colorado (2008–2021). A piecewise exponential Poisson regression model estimated age-specific HAEC incidence rates, adjusting for Trisomy 21 and length of aganglionosis. Seasonal distribution was assessed using an exact binomial test comparing cold (October–March) versus warm months.

Results

Among 217 patients, 96 HAEC episodes were identified in 53 patients (24.4%). HAEC incidence was highest in the first year of life and declined progressively with age, with an 88% reduction in patients older than 36 months (RR 0.12, 95% CI 0.07–0.22, p < 0.001). Additionally, 60.4% of episodes occurred during cold months, exceeding expected distribution (p = 0.03).

Conclusion

HAEC risk is strongly age-dependent, with a marked reduction after 36 months, supporting a role for immune maturation in disease susceptibility. The observed seasonal pattern suggests that viral exposures may act as triggers in susceptible patients.